DMN:FRA
Diamyd Medical AB
тВм┬ареж.режремрек
arrow_upward
+рез.репреи%(+реж.режрежрезреи) 1D
рдиреЛрднреЗрдореНрдмрд░ реиреж, режрео:режрек:релрез GMT+рез · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DMN...
Open
тВм┬ареж.режрем
High
тВм┬ареж.режрем
Low
тВм┬ареж.режрем
Mkt. cap
резрей.релрез┬ардХрд░реЛрдб
Avg. vol.
реж.режреж
Volume
реж.режреж
52-wk high
тВм┬арез.реореж
52-wk low
тВм┬ареж.режрел
No. of employees
рекреи
Open
тВм┬ареж.режрем
High
тВм┬ареж.режрем
Low
тВм┬ареж.режрем
Mkt. cap
резрей.релрез┬ардХрд░реЛрдб
Avg. vol.
реж.режреж
Volume
реж.режреж
52-wk high
тВм┬арез.реореж
52-wk low
тВм┬ареж.режрел
No. of employees
рекреи
News stories
From web sources and news partners
Reuters
·
рейрек рдорд┐рдиреЗрдЯ рдкрд╣рд┐рд▓реЗ
SocGen sees S&P 500 ending 2027 at 8,500 on AI, earnings support
Traders Union
·
рекрем рдорд┐рдиреЗрдЯ рдкрд╣рд┐рд▓реЗ
Ryan Detrick: S&P 500 posts six-day losing streak, longest since April 2024
Bloomberg.com
·
рез рдШрдгреНрдЯрд╛ рдкрд╣рд┐рд▓реЗ
S&P 500 Faces Technical Make-or-Break Moment Below 7,200 Line
Barron's
·
реи рдШрдгреНрдЯрд╛ рдкрд╣рд┐рд▓реЗ
S&P 500 Futures Decline in Premarket Trading; Lennar, Louisiana-Pacific Lag
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GADтВЖтВЕ, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Ume├е which utilizes bacuolavirus-mediated protein expression. Wikipedia
About Diamyd Medical AB
CEOUlf Hannelius
Employeesрекреи
Foundedрезрепреорек
Headquarters-
SectorHealth Care
Industry-
Websitediamyd.com